Molecular interactions of IRF4 in B cell development and malignancies

被引:0
|
作者
Srinivasan Sundararaj
Marco G. Casarotto
机构
[1] Australian National University,John Curtin School of Medical Research
来源
Biophysical Reviews | 2021年 / 13卷
关键词
Interferon regulatory factor 4; B cell development; Molecular interactions; B cell malignancies;
D O I
暂无
中图分类号
学科分类号
摘要
Interferon regulatory factor 4 (IRF4) is a lymphoid transcription factor and a key regulator in the development of various immune cells, including T and B cells. It is well-known that IRF4 controls numerous decision-making processes relating to B cell development, including differentiation, maturation, and signalling. Consequently, genetic alterations that affect the functional aspects of IRF4 can result in clonal transformation and have been identified in various lymphoid malignancies. Over the last decades, a series of studies have demonstrated the critical cellular and structural basis underpinning IRF4-mediated B cell development and associated malignancies. In this review, we will briefly summarise the recent advances in understanding IRF4-mediated B cell development and related malignancies, with a particular focus on the molecular aspects that govern these processes.
引用
收藏
页码:1219 / 1227
页数:8
相关论文
共 50 条
  • [41] Molecular analyses of pediatric type follicular lymphoma and large B cell lymphoma with IRF4 translocation in children and young adolescents
    Hawkins, Cynthia
    Kowalski, Paul
    Ngan, Bo-Yee
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 85 - 85
  • [42] Clinicopathological and Molecular Characteristics of Rare EBV-associated Diffuse Large B-cell Lymphoma With IRF4 Rearrangement
    Zhang, Yuxiu
    Li, Anqi
    Li, Yimin
    Ouyang, Binshen
    Wang, Xuan
    Zhang, Lei
    Xu, Haimin
    Gu, Yijin
    Lu, Xinyuan
    Dong, Lei
    Yi, Hongmei
    Wang, Chaofu
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (11) : 1341 - 1348
  • [43] IRF4 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasms
    van Slambrouck, C. M.
    Hyjek, E.
    Gurbuxani, S.
    LABORATORY INVESTIGATION, 2013, 93 : 364A - 365A
  • [44] IRF4 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasms
    van Slambrouck, C. M.
    Hyjek, E.
    Gurbuxani, S.
    MODERN PATHOLOGY, 2013, 26 : 364A - 365A
  • [45] A case of large B-cell lymphoma with IRF4 rearrangement in inguinal lymph nodes
    Masaoutis, C.
    Lampropoulou, P.
    Rontogianni, D.
    VIRCHOWS ARCHIV, 2019, 475 : S367 - S367
  • [46] IRF4 GENE REARRANGEMANT IN PEDIATRICANDADOLESCENT PATIENTS DIAGNOSED WITH LARGE B-CELL LYMPHOMA
    Gooch, M.
    Kirov, I.
    Frediani, J.
    Sassoon, A.
    Nael, A.
    Lin, C.
    LEUKEMIA RESEARCH, 2022, 121 : S43 - S43
  • [47] IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma
    Cakir, F. B.
    Guler, B.
    Cay, A.
    Mirapoglu, S.
    Turkmen, A. Vehaboglu
    Aki, H.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S196 - S196
  • [48] MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies
    K Tsuboi
    S Iida
    H Inagaki
    M Kato
    Y Hayami
    I Hanamura
    K Miura
    S Harada
    M Kikuchi
    H Komatsu
    S Banno
    A Wakita
    S Nakamura
    T Eimoto
    R Ueda
    Leukemia, 2000, 14 : 449 - 456
  • [49] Transcriptional Regulation of Germinal Center B and Plasma Cell Fates by Dynamical Control of IRF4
    Ochiai, Kyoko
    Maienschein-Cline, Mark
    Simonetti, Giorgia
    Chen, Jianjun
    Rosenthal, Rebecca
    Brink, Robert
    Chong, Anita S.
    Klein, Ulf
    Dinner, Aaron R.
    Singh, Harinder
    Sciammas, Roger
    IMMUNITY, 2013, 38 (05) : 918 - 929
  • [50] Super-enhancer analysis defines IRF4 as a target in anaplastic large cell lymphoma and rational design of IRF4 degrader molecules
    Giordano, C.
    Prutsch, N.
    Gurnhofer, E.
    Aplenc, A.
    Kenner, L.
    Look, A. T.
    Touaibia, M.
    Merkel, O.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 264 - 264